AbCellera Announces That The U.S. Patent Trial And Appeal Board Has Denied Berkeley Lights' Request For Rehearing
Portfolio Pulse from Happy Mohamed
The U.S. Patent Trial and Appeal Board (PTAB) has denied a rehearing request by Berkeley Lights, Inc. that challenged AbCellera's U.S. Patent No. 10,087,408. The patent is directed to microfluidic devices used in AbCellera's monoclonal antibody development engine. The decision strengthens AbCellera's patent claims and the company is looking forward to resuming its patent infringement cases against Berkeley Lights.
July 24, 2023 | 8:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The denial of Berkeley Lights' rehearing request by PTAB strengthens AbCellera's patent claims, which could potentially boost investor confidence in the company.
The PTAB's decision to deny Berkeley Lights' rehearing request strengthens AbCellera's patent claims. This could potentially boost investor confidence in the company as it shows that AbCellera's intellectual property is protected and that the company is committed to defending its patents. This could potentially have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100